25 XP   0   0   10

Renalytix AI plc
Buy, Hold or Sell?

Let's analyse Renalytix together

PenkeI guess you are interested in Renalytix AI plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Renalytix AI plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Renalytix AI plc

I send you an email if I find something interesting about Renalytix AI plc.

Quick analysis of Renalytix (30 sec.)










What can you expect buying and holding a share of Renalytix? (30 sec.)

How much money do you get?

How much money do you get?
p146.87
When do you have the money?
1 year
How often do you get paid?
90.9%

What is your share worth?

Current worth
p11.70
Expected worth in 1 year
p-50.99
How sure are you?
90.9%

+ What do you gain per year?

Total Gains per Share
p11,695.20
Return On Investment
47,735.5%

For what price can you sell your share?

Current Price per Share
p24.50
Expected price per share
p20.88 - p35.00
How sure are you?
50%

1. Valuation of Renalytix (5 min.)




Live pricePrice per Share (EOD)

p24.50

Intrinsic Value Per Share

p-893.50 - p330.53

Total Value Per Share

p-881.80 - p342.23

2. Growth of Renalytix (5 min.)




Is Renalytix growing?

Current yearPrevious yearGrowGrow %
How rich?$18.4m$43.1m-$24.7m-133.9%

How much money is Renalytix making?

Current yearPrevious yearGrowGrow %
Making money-$46.2m-$56.7m$10.5m22.7%
Net Profit Margin-1,358.3%-1,910.2%--

How much money comes from the company's main activities?

3. Financial Health of Renalytix (5 min.)




4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  


Richest
#92 / 120

Most Revenue
#107 / 120

Most Profit
#93 / 120

Most Efficient
#117 / 120

What can you expect buying and holding a share of Renalytix? (5 min.)

Welcome investor! Renalytix's management wants to use your money to grow the business. In return you get a share of Renalytix.

What can you expect buying and holding a share of Renalytix?

First you should know what it really means to hold a share of Renalytix. And how you can make/lose money.

Speculation

The Price per Share of Renalytix is p24.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Renalytix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Renalytix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p11.70. Based on the TTM, the Book Value Change Per Share is p-15.67 per quarter. Based on the YOY, the Book Value Change Per Share is p-32.93 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p2,939.47 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Renalytix.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps-0.36-1.5%-0.36-1.5%-0.36-1.5%-0.21-0.8%0.893.6%
Usd Book Value Change Per Share-0.20-0.8%-0.20-0.8%-0.41-1.7%0.030.1%-0.64-2.6%
Usd Dividend Per Share36.72149.9%36.72149.9%40.42165.0%31.45128.4%14.9360.9%
Usd Total Gains Per Share36.52149.1%36.52149.1%40.00163.3%31.48128.5%14.2958.3%
Usd Price Per Share1.41-1.41-1.31-5.31-2.42-
Price to Earnings Ratio-3.89--3.89--3.66--406.82--184.92-
Price-to-Total Gains Ratio0.04-0.04-0.03-0.93-0.93-
Price to Book Ratio9.61-9.61-3.84-106.43-48.38-
Price-to-Total Gains Ratio0.04-0.04-0.03-0.93-0.93-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.3060295
Number of shares3267
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share36.7231.45
Usd Book Value Change Per Share-0.200.03
Usd Total Gains Per Share36.5231.48
Gains per Quarter (3267 shares)119,314.75102,829.71
Gains per Year (3267 shares)477,259.00411,318.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1479817-2558477249410937382411309
2959635-5117954508821873764822628
31439452-76751431767123281011471233947
41919269-102331909026164374615291645266
52399086-127912386285205468319112056585
62878904-153502863544246562022932467904
73358721-179083340803287655626762879223
83838538-204663818062328749330583290542
94318356-230254295321369842934403701861
104798173-255834772580410936638224113180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%5.06.00.045.5%6.06.00.050.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.06.00.045.5%6.06.00.050.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.01.090.9%11.00.01.091.7%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.01.00.090.9%11.01.00.091.7%

Fundamentals of Renalytix

About Renalytix AI plc

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix Plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; and Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is based in New York, New York.

Fundamental data was last updated by Penke on 2024-04-24 19:25:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Renalytix AI plc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Renalytix earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • A Net Profit Margin of -1,358.3% means that -13.58 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Renalytix AI plc:

  • The MRQ is -1,358.3%. The company is making a huge loss. -2
  • The TTM is -1,358.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,358.3%TTM-1,358.3%0.0%
TTM-1,358.3%YOY-1,910.2%+551.9%
TTM-1,358.3%5Y-1,067.5%-290.8%
5Y-1,067.5%10Y-480.6%-586.9%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,358.3%-21.3%-1,337.0%
TTM-1,358.3%-20.1%-1,338.2%
YOY-1,910.2%-29.8%-1,880.4%
5Y-1,067.5%-36.1%-1,031.4%
10Y-480.6%-42.2%-438.4%
1.1.2. Return on Assets

Shows how efficient Renalytix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • -109.7% Return on Assets means that Renalytix generated -1.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Renalytix AI plc:

  • The MRQ is -109.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -109.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-109.7%TTM-109.7%0.0%
TTM-109.7%YOY-89.7%-20.1%
TTM-109.7%5Y3,005.9%-3,115.6%
5Y3,005.9%10Y1,169.7%+1,836.1%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-109.7%-6.5%-103.2%
TTM-109.7%-6.0%-103.7%
YOY-89.7%-5.4%-84.3%
5Y3,005.9%-5.3%+3,011.2%
10Y1,169.7%-7.4%+1,177.1%
1.1.3. Return on Equity

Shows how efficient Renalytix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • -250.5% Return on Equity means Renalytix generated -2.50 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Renalytix AI plc:

  • The MRQ is -250.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -250.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-250.5%TTM-250.5%0.0%
TTM-250.5%YOY-131.4%-119.1%
TTM-250.5%5Y3,422.2%-3,672.7%
5Y3,422.2%10Y1,566.4%+1,855.8%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-250.5%-6.6%-243.9%
TTM-250.5%-6.8%-243.7%
YOY-131.4%-6.7%-124.7%
5Y3,422.2%-8.4%+3,430.6%
10Y1,566.4%-9.6%+1,576.0%

1.2. Operating Efficiency of Renalytix AI plc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Renalytix is operating .

  • Measures how much profit Renalytix makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • An Operating Margin of -1,116.3% means the company generated -11.16  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Renalytix AI plc:

  • The MRQ is -1,116.3%. The company is operating very inefficient. -2
  • The TTM is -1,116.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,116.3%TTM-1,116.3%0.0%
TTM-1,116.3%YOY-1,606.9%+490.5%
TTM-1,116.3%5Y-1,097.6%-18.7%
5Y-1,097.6%10Y-491.9%-605.7%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,116.3%-23.8%-1,092.5%
TTM-1,116.3%-16.4%-1,099.9%
YOY-1,606.9%-23.4%-1,583.5%
5Y-1,097.6%-18.4%-1,079.2%
10Y-491.9%-31.6%-460.3%
1.2.2. Operating Ratio

Measures how efficient Renalytix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 13.45 means that the operating costs are 13.45 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Renalytix AI plc:

  • The MRQ is 13.446. The company is inefficient in keeping operating costs low. -1
  • The TTM is 13.446. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ13.446TTM13.4460.000
TTM13.446YOY20.317-6.871
TTM13.4465Y11.493+1.953
5Y11.49310Y5.609+5.884
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ13.4461.370+12.076
TTM13.4461.385+12.061
YOY20.3171.389+18.928
5Y11.4931.398+10.095
10Y5.6091.331+4.278

1.3. Liquidity of Renalytix AI plc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Renalytix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 1.76 means the company has 1.76 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Renalytix AI plc:

  • The MRQ is 1.756. The company is able to pay all its short-term debts. +1
  • The TTM is 1.756. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.756TTM1.7560.000
TTM1.756YOY3.886-2.130
TTM1.7565Y6.828-5.072
5Y6.82810Y3.421+3.407
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7561.770-0.014
TTM1.7561.813-0.057
YOY3.8862.099+1.787
5Y6.8282.589+4.239
10Y3.4212.589+0.832
1.3.2. Quick Ratio

Measures if Renalytix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • A Quick Ratio of 1.77 means the company can pay off 1.77 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Renalytix AI plc:

  • The MRQ is 1.767. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.767. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.767TTM1.7670.000
TTM1.767YOY4.016-2.249
TTM1.7675Y-1,045.007+1,046.774
5Y-1,045.00710Y-474.851-570.156
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7671.059+0.708
TTM1.7671.223+0.544
YOY4.0161.723+2.293
5Y-1,045.0072.117-1,047.124
10Y-474.8512.107-476.958

1.4. Solvency of Renalytix AI plc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Renalytix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Renalytix to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.56 means that Renalytix assets are financed with 56.2% credit (debt) and the remaining percentage (100% - 56.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Renalytix AI plc:

  • The MRQ is 0.562. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.562. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.562TTM0.5620.000
TTM0.562YOY0.318+0.244
TTM0.5625Y0.222+0.340
5Y0.22210Y0.522-0.300
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5620.379+0.183
TTM0.5620.381+0.181
YOY0.3180.415-0.097
5Y0.2220.411-0.189
10Y0.5220.453+0.069
1.4.2. Debt to Equity Ratio

Measures if Renalytix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • A Debt to Equity ratio of 128.2% means that company has 1.28 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Renalytix AI plc:

  • The MRQ is 1.282. The company is able to pay all its debts with equity. +1
  • The TTM is 1.282. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.282TTM1.2820.000
TTM1.282YOY0.465+0.817
TTM1.2825Y0.400+0.882
5Y0.40010Y0.907-0.506
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2820.578+0.704
TTM1.2820.575+0.707
YOY0.4650.614-0.149
5Y0.4000.709-0.309
10Y0.9070.616+0.291

2. Market Valuation of Renalytix AI plc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Renalytix generates.

  • Above 15 is considered overpriced but always compare Renalytix to the Health Information Services industry mean.
  • A PE ratio of -3.89 means the investor is paying -3.89 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Renalytix AI plc:

  • The EOD is -0.847. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.890. Based on the earnings, the company is expensive. -2
  • The TTM is -3.890. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.847MRQ-3.890+3.043
MRQ-3.890TTM-3.8900.000
TTM-3.890YOY-3.657-0.233
TTM-3.8905Y-406.824+402.934
5Y-406.82410Y-184.920-221.904
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-0.847-1.534+0.687
MRQ-3.890-2.131-1.759
TTM-3.890-2.131-1.759
YOY-3.657-3.492-0.165
5Y-406.824-5.005-401.819
10Y-184.920-4.981-179.939
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Renalytix AI plc:

  • The EOD is -1.158. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.317. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.317. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.158MRQ-5.317+4.159
MRQ-5.317TTM-5.3170.000
TTM-5.317YOY-3.566-1.751
TTM-5.3175Y-326.376+321.060
5Y-326.37610Y-148.353-178.024
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-1.158-1.376+0.218
MRQ-5.317-1.754-3.563
TTM-5.317-2.380-2.937
YOY-3.566-5.605+2.039
5Y-326.376-3.847-322.529
10Y-148.353-3.041-145.312
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Renalytix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 9.61 means the investor is paying 9.61 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Renalytix AI plc:

  • The EOD is 2.094. Based on the equity, the company is underpriced. +1
  • The MRQ is 9.613. Based on the equity, the company is overpriced. -1
  • The TTM is 9.613. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD2.094MRQ9.613-7.520
MRQ9.613TTM9.6130.000
TTM9.613YOY3.836+5.778
TTM9.6135Y106.428-96.815
5Y106.42810Y48.376+58.052
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD2.0941.747+0.347
MRQ9.6131.846+7.767
TTM9.6131.949+7.664
YOY3.8362.960+0.876
5Y106.4283.999+102.429
10Y48.3764.198+44.178
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Renalytix AI plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---15.673-15.6730%-32.933+110%2.342-769%-51.411+228%
Book Value Per Share--11.70211.7020%27.375-57%23.668-51%241.293-95%
Current Ratio--1.7561.7560%3.886-55%6.828-74%3.421-49%
Debt To Asset Ratio--0.5620.5620%0.318+77%0.222+154%0.522+8%
Debt To Equity Ratio--1.2821.2820%0.465+176%0.400+220%0.907+41%
Dividend Per Share--2939.4742939.4740%3235.638-9%2517.494+17%1195.346+146%
Eps---28.921-28.9210%-28.711-1%-16.613-43%70.915-141%
Free Cash Flow Per Share---21.160-21.1600%-29.449+39%-15.683-26%75.217-128%
Free Cash Flow To Equity Per Share---11.573-11.5730%-13.269+15%2.696-529%21.488-154%
Gross Profit Margin--182.177182.1770%138.888+31%120.423+51%54.620+234%
Intrinsic Value_10Y_max--330.527--------
Intrinsic Value_10Y_min---893.500--------
Intrinsic Value_1Y_max--66.290--------
Intrinsic Value_1Y_min---39.745--------
Intrinsic Value_3Y_max--173.896--------
Intrinsic Value_3Y_min---163.249--------
Intrinsic Value_5Y_max--251.028--------
Intrinsic Value_5Y_min---333.844--------
Market Cap3092365500.000-359%14199637500.00014199637500.0000%13252995000.000+7%318948465732.000-96%144976575332.727-90%
Net Profit Margin---13.583-13.5830%-19.102+41%-10.675-21%-4.806-65%
Operating Margin---11.163-11.1630%-16.069+44%-10.976-2%-4.919-56%
Operating Ratio--13.44613.4460%20.317-34%11.493+17%5.609+140%
Pb Ratio2.094-359%9.6139.6130%3.836+151%106.428-91%48.376-80%
Pe Ratio-0.847+78%-3.890-3.8900%-3.657-6%-406.824+10358%-184.920+4654%
Price Per Share24.500-359%112.500112.5000%105.000+7%425.500-74%193.409-42%
Price To Free Cash Flow Ratio-1.158+78%-5.317-5.3170%-3.566-33%-326.376+6039%-148.353+2690%
Price To Total Gains Ratio0.008-359%0.0380.0380%0.033+17%0.933-96%0.933-96%
Quick Ratio--1.7671.7670%4.016-56%-1045.007+59234%-474.851+26970%
Return On Assets---1.097-1.0970%-0.897-18%30.059-104%11.697-109%
Return On Equity---2.505-2.5050%-1.314-48%34.222-107%15.664-116%
Total Gains Per Share--2923.8012923.8010%3202.705-9%2519.836+16%1143.935+156%
Usd Book Value--18449933.47718449933.4770%43159487.279-57%44161066.523-58%8279737497.995-100%
Usd Book Value Change Per Share---0.196-0.1960%-0.411+110%0.029-769%-0.642+228%
Usd Book Value Per Share--0.1460.1460%0.342-57%0.296-51%3.014-95%
Usd Dividend Per Share--36.71736.7170%40.416-9%31.446+17%14.931+146%
Usd Eps---0.361-0.3610%-0.359-1%-0.208-43%0.886-141%
Usd Free Cash Flow---33360647.028-33360647.0280%-46428766.702+39%-26891072.977-19%2688393055.315-101%
Usd Free Cash Flow Per Share---0.264-0.2640%-0.368+39%-0.196-26%0.940-128%
Usd Free Cash Flow To Equity Per Share---0.145-0.1450%-0.166+15%0.034-529%0.268-154%
Usd Market Cap38626737.461-359%177367672.013177367672.0130%165543160.545+7%3983985285.458-96%1810902402.481-90%
Usd Price Per Share0.306-359%1.4051.4050%1.312+7%5.315-74%2.416-42%
Usd Profit---46212814.300-46212814.3000%-56719498.536+23%1233741388.226-104%3372888951.736-101%
Usd Revenue--3402250.1153402250.1150%2969345.531+15%11660247874.049-100%33020288321.677-100%
Usd Total Gains Per Share--36.52136.5210%40.005-9%31.475+16%14.289+156%
 EOD+2 -6MRQTTM+0 -0YOY+19 -175Y+8 -2810Y+10 -26

3.2. Fundamental Score

Let's check the fundamental score of Renalytix AI plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.847
Price to Book Ratio (EOD)Between0-12.094
Net Profit Margin (MRQ)Greater than0-13.583
Operating Margin (MRQ)Greater than0-11.163
Quick Ratio (MRQ)Greater than11.767
Current Ratio (MRQ)Greater than11.756
Debt to Asset Ratio (MRQ)Less than10.562
Debt to Equity Ratio (MRQ)Less than11.282
Return on Equity (MRQ)Greater than0.15-2.505
Return on Assets (MRQ)Greater than0.05-1.097
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Renalytix AI plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.077
Ma 20Greater thanMa 5029.350
Ma 50Greater thanMa 10032.305
Ma 100Greater thanMa 20023.957
OpenGreater thanClose25.200
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets42,117
Total Liabilities23,663
Total Stockholder Equity18,454
 As reported
Total Liabilities 23,663
Total Stockholder Equity+ 18,454
Total Assets = 42,117

Assets

Total Assets42,117
Total Current Assets28,334
Long-term Assets13,783
Total Current Assets
Cash And Cash Equivalents 24,682
Short-term Investments 1,460
Net Receivables 908
Inventory 718
Other Current Assets 566
Total Current Assets  (as reported)28,334
Total Current Assets  (calculated)28,334
+/-0
Long-term Assets
Property Plant Equipment 1,221
Goodwill 23,138,452
Intangible Assets 14,020
Long-term Assets Other 51
Long-term Assets  (as reported)13,783
Long-term Assets  (calculated)23,153,744
+/- 23,139,961

Liabilities & Shareholders' Equity

Total Current Liabilities16,133
Long-term Liabilities7,530
Total Stockholder Equity18,454
Total Current Liabilities
Short-term Debt 4,619
Short Long Term Debt 4,463
Accounts payable 11,514
Other Current Liabilities 10
Total Current Liabilities  (as reported)16,133
Total Current Liabilities  (calculated)20,606
+/- 4,473
Long-term Liabilities
Long term Debt 7,485
Capital Lease Obligations 202
Long-term Liabilities Other -1
Long-term Liabilities  (as reported)7,530
Long-term Liabilities  (calculated)7,686
+/- 156
Total Stockholder Equity
Common Stock299
Retained Earnings -99,184
Other Stockholders Equity 117,339
Total Stockholder Equity (as reported)18,454
Total Stockholder Equity (calculated)18,454
+/-0
Other
Capital Stock299
Cash and Short Term Investments 26,142
Common Stock Shares Outstanding 82,210
Current Deferred Revenue-10
Liabilities and Stockholders Equity 42,117
Net Debt -12,532
Net Invested Capital 30,402
Net Tangible Assets 6,967
Net Working Capital 12,201
Property Plant and Equipment Gross 1,221
Short Long Term Debt Total 12,150



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302018-01-012016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
60,899,202
62,677,133
58,133,511
56,799,348
59,392,696
0
57
28,922
41,298
102,578
63,258
42,117
42,11763,258102,57841,29828,92257059,392,69656,799,34858,133,51162,677,13360,899,202
   > Total Current Assets 
16,015,558
16,693,521
14,945,228
13,777,898
14,613,199
0
57
9,398
18,896
76,007
47,431
28,334
28,33447,43176,00718,8969,39857014,613,19913,777,89814,945,22816,693,52116,015,558
       Cash And Cash Equivalents 
3,250,049
3,146,733
2,603,643
2,500,136
3,559,625
0
42
9,288
13,293
65,159
41,333
24,682
24,68241,33365,15913,2939,2884203,559,6252,500,1362,603,6433,146,7333,250,049
       Short-term Investments 
937,438
1,286,236
725,050
647,298
594,674
0
0
956,582
982
9,295
2,744
1,460
1,4602,7449,295982956,58200594,674647,298725,0501,286,236937,438
       Net Receivables 
0
0
0
0
0
0
15
-4,927,254
18
18
2,195
908
9082,1951818-4,927,25415000000
       Inventory 
5,848,771
5,421,745
5,045,089
4,708,118
4,502,684
0
0
4,927,254
326
353
1,160
718
7181,1603533264,927,254004,502,6844,708,1185,045,0895,421,7455,848,771
   > Long-term Assets 
41,772,035
42,360,394
40,357,078
39,868,585
41,676,666
0
0
19,524
22,402
26,571
15,827
13,783
13,78315,82726,57122,40219,5240041,676,66639,868,58540,357,07842,360,39441,772,035
       Property Plant Equipment 
12,453,029
12,867,865
12,675,664
12,009,775
12,286,075
0
0
278
945
2,459
3,091
1,221
1,2213,0912,4599452780012,286,07512,009,77512,675,66412,867,86512,453,029
       Goodwill 
19,274,837
19,165,462
17,723,174
17,608,471
18,549,626
0
0
19,865,964
20,265,844
23,139,506
23,139,085
23,138,452
23,138,45223,139,08523,139,50620,265,84419,865,9640018,549,62617,608,47117,723,17419,165,46219,274,837
       Long Term Investments 
0
0
0
0
0
0
0
0
1,937
0
0
0
0001,93700000000
       Intangible Assets 
9,359,879
9,621,979
9,116,988
9,607,385
10,324,176
0
0
18,287
17,118
18,021
14,020
14,020
14,02014,02018,02117,11818,2870010,324,1769,607,3859,116,9889,621,9799,359,879
       Other Assets 
3,111,609
3,623,218
2,831,205
3,152,865
3,102,831
0
0
959
2,402
7,172
1,189
1,101
1,1011,1897,1722,402959003,102,8313,152,8652,831,2053,623,2183,111,609
> Total Liabilities 
39,870,789
42,275,012
40,869,092
39,333,152
41,520,893
0
66
755
5,336
7,476
20,089
23,663
23,66320,0897,4765,33675566041,520,89339,333,15240,869,09242,275,01239,870,789
   > Total Current Liabilities 
20,851,737
23,937,203
23,775,343
21,742,058
21,635,617
0
66
755
3,383
7,263
12,205
16,133
16,13312,2057,2633,38375566021,635,61721,742,05823,775,34323,937,20320,851,737
       Short-term Debt 
0
0
0
0
0
0
66
0
213
139
4,823
4,619
4,6194,823139213066000000
       Short Long Term Debt 
0
0
0
0
0
0
66
0
121
53
4,660
4,463
4,4634,66053121066000000
       Accounts payable 
9,340,102
9,632,996
9,242,874
9,010,046
9,042,206
0
0
755
2,899
1,765
2,460
11,514
11,5142,4601,7652,899755009,042,2069,010,0469,242,8749,632,9969,340,102
       Other Current Liabilities 
11,511,636
14,304,207
14,532,470
12,732,012
12,593,411
0
66
440
13,222,658
14,924,261
18,076,485
10
1018,076,48514,924,26113,222,65844066012,593,41112,732,01214,532,47014,304,20711,511,636
   > Long-term Liabilities 
9,727,734
10,054,396
8,473,038
10,530,546
11,589,306
0
0
24,669,492
1,953
213
7,884
7,530
7,5307,8842131,95324,669,4920011,589,30610,530,5468,473,03810,054,3969,727,734
       Other Liabilities 
0
0
0
0
0
0
0
0
1,544
53
0
0
00531,54400000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
1,740
2,364
0
0
0
0002,3641,7400000000
> Total Stockholder Equity
28,278,726
28,853,543
25,472,372
25,091,501
24,905,799
0
-9
28,167
35,962
95,102
43,169
18,454
18,45443,16995,10235,96228,167-9024,905,79925,091,50125,472,37228,853,54328,278,726
   Common Stock
638,144
666,529
585,850
525,658
509,420
0
70
175
192
233
241
299
299241233192175700509,420525,658585,850666,529638,144
   Retained Earnings 
27,640,583
28,187,014
24,886,522
24,565,843
24,396,379
0
-79
-5,977
34,852
3,771
-52,961
-99,184
-99,184-52,9613,77134,852-5,977-79024,396,37924,565,84324,886,52228,187,01427,640,583
   Accumulated Other Comprehensive Income 00-1,915-1,915-5950000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
76,457
0
0
0076,457000000000
   Treasury Stock000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue2,893
Cost of Revenue-2,489
Gross Profit404404
 
Operating Income (+$)
Gross Profit404
Operating Expense-42,281
Operating Income-39,388-41,877
 
Operating Expense (+$)
Research Development13,328
Selling General Administrative26,471
Selling And Marketing Expenses-
Operating Expense42,28139,799
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-39,388
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-43,805-39,388
EBIT - interestExpense = 0
-43,808
-43,808
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--43,805
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-43,805
Tax Provision-3
Net Income From Continuing Ops-43,808-43,808
Net Income-43,808
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Renalytix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Renalytix. The general trend of Renalytix is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Renalytix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Renalytix AI plc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 27.00 < 27.00 < 35.00.

The bearish price targets are: 25.00 > 24.00 > 20.88.

Tweet this
Renalytix AI plc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Renalytix AI plc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Renalytix AI plc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Renalytix AI plc. The current macd is -1.53468656.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Renalytix price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Renalytix. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Renalytix price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Renalytix AI plc Daily Moving Average Convergence/Divergence (MACD) ChartRenalytix AI plc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Renalytix AI plc. The current adx is 16.82.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Renalytix shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Renalytix AI plc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Renalytix AI plc. The current sar is 49.13.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Renalytix AI plc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Renalytix AI plc. The current rsi is 34.08. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Renalytix AI plc Daily Relative Strength Index (RSI) ChartRenalytix AI plc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Renalytix AI plc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Renalytix price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Renalytix AI plc Daily Stochastic Oscillator ChartRenalytix AI plc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Renalytix AI plc. The current cci is -188.24181994.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Renalytix AI plc Daily Commodity Channel Index (CCI) ChartRenalytix AI plc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Renalytix AI plc. The current cmo is -54.30328578.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Renalytix AI plc Daily Chande Momentum Oscillator (CMO) ChartRenalytix AI plc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Renalytix AI plc. The current willr is -95.45454545.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Renalytix AI plc Daily Williams %R ChartRenalytix AI plc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Renalytix AI plc.

Renalytix AI plc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Renalytix AI plc. The current atr is 2.6954867.

Renalytix AI plc Daily Average True Range (ATR) ChartRenalytix AI plc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Renalytix AI plc. The current obv is 4,193,293.

Renalytix AI plc Daily On-Balance Volume (OBV) ChartRenalytix AI plc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Renalytix AI plc. The current mfi is 64.62.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Renalytix AI plc Daily Money Flow Index (MFI) ChartRenalytix AI plc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Renalytix AI plc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Renalytix AI plc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Renalytix AI plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.077
Ma 20Greater thanMa 5029.350
Ma 50Greater thanMa 10032.305
Ma 100Greater thanMa 20023.957
OpenGreater thanClose25.200
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Renalytix with someone you think should read this too:
  • Are you bullish or bearish on Renalytix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Renalytix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Renalytix AI plc

I send you an email if I find something interesting about Renalytix AI plc.


Comments

How you think about this?

Leave a comment

Stay informed about Renalytix AI plc.

Receive notifications about Renalytix AI plc in your mailbox!